Clinical Trial Update: The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is assessing the safety and efficacy of terpene-enriched cannabidiol (CBD) oil in Attention-deficit/hyperactivity disorder (ADHD). The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Terpene-enriched cannabidiol (CBD) oil (cannabidiol (CBD))

Snippet

Sponsor: Bazelet Nehushtan LtD. | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 2 | Status: RECRUITING